Hypertrombopa
CTIT-Chemotherapy Induced Thrombocytopenia
Jinhua Central HospitalActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
18 Active assets in the CTIT-Chemotherapy Induced Thrombocytopenia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Recombinant Human Thrombopoietin Sun Yat-sen University | Phase 4 | BBB |
sb-497115-gr Institute of Hematology & Blood Diseases Hospital, China | Phase 4 | BB |
Avatrombopag Second Affiliated Hospital of Guangzhou Medical University | Phase 4 | BB |
FILGRASTIM OHSU Knight Cancer Institute | Phase 2 | BB |
Hetrombopag Sun Yat-sen University | Phase 3 | BB |
View all 50 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →